SPC advises no dose adjustment is needed during short-term use of azithromycin when administered concomitantly with venetoclax, but co-administration of narrow therapeutic index P-gp, or breast cancer resistance protein (BCRP) substrates (e.g. digoxin, dabigatran, everolimus, sirolimus) with venetoclax should be avoided.